Glaxosmithkline | مبيعات



Sales تغيير تاريخ
AbbVie USD 15.42B 2.08B 2025-06
Amgen USD 9.18B 1.03B 2025-06
AstraZeneca USD 14.46B 867M 2025-06
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bausch Health Companies USD 2.53B 270M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 194.4M 37.2M 2025-06
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 15.56B 2.83B 2025-06
GlaxoSmithKline GBP 7.99B 470M 2025-06
Glaxosmithkline GBP 8.12B 105M 2024-12
J&J USD 23.74B 1.85B 2025-06
Merck USD 15.81B 280M 2025-06
Novartis USD 14.05B 821M 2025-06
Pacira USD 181.1M 12.18M 2025-06
Perrigo USD 1.06B 20M 2025-06
Pfizer USD 14.7B 980M 2025-06
Prestige Brands USD 249.53M 46.99M 2025-06
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.99B 90M 2025-06
Supernus Pharmaceuticals USD 165.5M 15.7M 2025-06
Takeda JPY 1.11T 60B 2025-06
Teva Pharmaceutical Industries USD 14.06B 0 2025-06
Zoetis USD 2.46B 240M 2025-06


Glaxosmithkline مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.